The report analyzes and forecasts the pediatric health care products and services market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of pediatric health care products and services, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major pediatric health care products and services companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of pediatric health care products and services upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of pediatric health care products and services and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global pediatric health care products and services market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the pediatric health care products and services market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of pediatric health care products and services market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Companies Mentioned in Report
The report also profiles major players in the global pediatric health care products and services market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players in the market include Pfizer Inc., GlaxoSmithKline plc. Merck & Co., Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Gilead Sciences, Inc., Sanofi S.A., Pediapharm, Inc., Novartis AG, Eisai Co., Ltd. and Mylan N.V.
The global pediatric health care products and services market is segmented as given below:
Global Pediatric Health Care Products and Services Market, by Region
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pediatric Health Care Products and Services Market
4. Market Overview
4.1. Introduction
4.1.1. Disorder/Disease Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, 2017–2026
4.4.1. Market Revenue Projections, by Product Type (US$ Mn)
4.4.2. Market Revenue Projections, by Services Type (US$ Mn)
5. Market Overview
5.1. Clinical Trial Analysis
5.2. Disease Incidence and Prevalence
5.3. Regulatory Framework
6. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Disorder/Disease
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast by Disorder/Disease, 2017–2026
6.3.1. Allergy and Respiratory
6.3.2. Cancer
6.3.3. Cardiovascular
6.3.4. Central Nervous System
6.3.5. Gastrointestinal
6.3.6. Hormonal Imbalance
6.3.7. Infections
6.3.8. Others
6.4. Market Attractiveness by Disorder/Disease
7. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Drug Class
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast by Drug Class, 2017–2026
7.3.1. Antibiotics
7.3.2. Analgesics
7.3.3. Anti-asthmatics
7.3.4. Antidepressants
7.3.5. Antidiarrheal
7.3.6. Antifungal
7.3.7. Anti-histamines
7.3.8. Antihypertensives
7.3.9. Anti-metabolites
7.3.10. Anti-neoplastic Antibiotics
7.3.11. Antipsychotics
7.3.12. Others
8. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Services
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast by Services, 2017–2026
8.3.1. Child Psychiatry Services
8.3.2. Gastrointestinal Services
8.3.3. Pediatric Cancer Services
8.3.4. Pediatric Diabetes Services
8.3.5. Pediatric Heart Services
8.3.6. Others
9. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness by Country/Region
10. North America Pediatric Health Care Products and Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast by Disorder/Disease, 2017–2026
10.2.1. Allergy and Respiratory
10.2.2. Cancer
10.2.3. Cardiovascular
10.2.4. Central Nervous System
10.2.5. Gastrointestinal
10.2.6. Hormonal Imbalance
10.2.7. Infections
10.2.8. Others
10.3. Market Value Forecast by Drug Class, 2017–2026
10.3.1. Antibiotics
10.3.2. Analgesics
10.3.3. Anti-asthmatics
10.3.4. Antidepressants
10.3.5. Antidiarrheal
10.3.6. Antifungal
10.3.7. Anti-histamines
10.3.8. Antihypertensives
10.3.9. Anti-metabolites
10.3.10. Anti-neoplastic Antibiotics
10.3.11. Antipsychotics
10.3.12. Others
10.4. Market Value Forecast by Services, 2017–2026
10.4.1. Child Psychiatry Services
10.4.2. Gastrointestinal Services
10.4.3. Pediatric Cancer Services
10.4.4. Pediatric Diabetes Services
10.4.5. Pediatric Heart Services
10.4.6. Others
10.5. Market Value Forecast by Country, 2017–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Disorder/Disease
10.6.2. By Drug Class
10.6.3. By Services
10.6.4. By Country
11. Europe Pediatric Health Care Products and Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast by Disorder/Disease, 2017–2026
11.2.1. Allergy and Respiratory
11.2.2. Cancer
11.2.3. Cardiovascular
11.2.4. Central Nervous System
11.2.5. Gastrointestinal
11.2.6. Hormonal Imbalance
11.2.7. Infections
11.2.8. Others
11.3. Market Value Forecast by Drug Class, 2017–2026
11.3.1. Antibiotics
11.3.2. Analgesics
11.3.3. Anti-asthmatics
11.3.4. Antidepressants
11.3.5. Antidiarrheal
11.3.6. Antifungal
11.3.7. Anti-histamines
11.3.8. Antihypertensives
11.3.9. Anti-metabolites
11.3.10. Anti-neoplastic Antibiotics
11.3.11. Antipsychotics
11.3.12. Others
11.4. Market Value Forecast by Services, 2017–2026
11.4.1. Child Psychiatry Services
11.4.2. Gastrointestinal Services
11.4.3. Pediatric Cancer Services
11.4.4. Pediatric Diabetes Services
11.4.5. Pediatric Heart Services
11.4.6. Others
11.5. Market Value Forecast by Country, 2017–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Disorder/Disease
11.6.2. By Drug Class
11.6.3. By Services
11.6.4. By Country
12. Asia Pacific Pediatric Health Care Products and Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast by Disorder/Disease, 2017–2026
12.2.1. Allergy and Respiratory
12.2.2. Cancer
12.2.3. Cardiovascular
12.2.4. Central Nervous System
12.2.5. Gastrointestinal
12.2.6. Hormonal Imbalance
12.2.7. Infections
12.2.8. Others
12.3. Market Value Forecast by Drug Class, 2017–2026
12.3.1. Antibiotics
12.3.2. Analgesics
12.3.3. Anti-asthmatics
12.3.4. Antidepressants
12.3.5. Antidiarrheal
12.3.6. Antifungal
12.3.7. Anti-histamines
12.3.8. Antihypertensives
12.3.9. Anti-metabolites
12.3.10. Anti-neoplastic Antibiotics
12.3.11. Antipsychotics
12.3.12. Others
12.4. Market Value Forecast by Services, 2017–2026
12.4.1. Child Psychiatry Services
12.4.2. Gastrointestinal Services
12.4.3. Pediatric Cancer Services
12.4.4. Pediatric Diabetes Services
12.4.5. Pediatric Heart Services
12.4.6. Others
12.5. Market Value Forecast by Country, 2017–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Disorder/Disease
12.6.2. By Drug Class
12.6.3. By Services
12.6.4. By Country
13. Latin America Pediatric Health Care Products and Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast by Disorder/Disease, 2017–2026
13.2.1. Allergy and Respiratory
13.2.2. Cancer
13.2.3. Cardiovascular
13.2.4. Central Nervous System
13.2.5. Gastrointestinal
13.2.6. Hormonal Imbalance
13.2.7. Infections
13.2.8. Others
13.3. Market Value Forecast by Drug Class, 2017–2026
13.3.1. Antibiotics
13.3.2. Analgesics
13.3.3. Anti-asthmatics
13.3.4. Antidepressants
13.3.5. Antidiarrheal
13.3.6. Antifungal
13.3.7. Anti-histamines
13.3.8. Antihypertensives
13.3.9. Anti-metabolites
13.3.10. Anti-neoplastic Antibiotics
13.3.11. Antipsychotics
13.3.12. Others
13.4. Market Value Forecast by Services, 2017–2026
13.4.1. Child Psychiatry Services
13.4.2. Gastrointestinal Services
13.4.3. Pediatric Cancer Services
13.4.4. Pediatric Diabetes Services
13.4.5. Pediatric Heart Services
13.4.6. Others
13.5. Market Value Forecast by Country, 2017–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Disorder/Disease
13.6.2. By Drug Class
13.6.3. By Services
13.6.4. By Country
14. Middle East & Africa Pediatric Health Care Products and Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast by Disorder/Disease, 2017–2026
14.2.1. Allergy and Respiratory
14.2.2. Cancer
14.2.3. Cardiovascular
14.2.4. Central Nervous System
14.2.5. Gastrointestinal
14.2.6. Hormonal Imbalance
14.2.7. Infections
14.2.8. Others
14.3. Market Value Forecast by Drug Class, 2017–2026
14.3.1. Antibiotics
14.3.2. Analgesics
14.3.3. Anti-asthmatics
14.3.4. Antidepressants
14.3.5. Antidiarrheal
14.3.6. Antifungal
14.3.7. Anti-histamines
14.3.8. Antihypertensives
14.3.9. Anti-metabolites
14.3.10. Anti-neoplastic Antibiotics
14.3.11. Antipsychotics
14.3.12. Others
14.4. Market Value Forecast by Services, 2017–2026
14.4.1. Child Psychiatry Services
14.4.2. Gastrointestinal Services
14.4.3. Pediatric Cancer Services
14.4.4. Pediatric Diabetes Services
14.4.5. Pediatric Heart Services
14.4.6. Others
14.5. Market Value Forecast by Country, 2017–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Disorder/Disease
14.6.2. By Drug Class
14.6.3. By Services
14.6.4. By Country
15. Competition Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Company Profiles
15.2.1. AstraZeneca plc
15.2.1.1. Overview (HQ, Employee Strength, Business Segments)
15.2.1.2. Financials
15.2.1.3. Recent Development
15.2.1.4. Strategy
15.2.2. Boehringer Ingelheim GmbH
15.2.2.1. Overview (HQ, Employee Strength, Business Segments)
15.2.2.2. Financials
15.2.2.3. Recent Development
15.2.2.4. Strategy
15.2.3. Eisai Co., Ltd.
15.2.3.1. Overview (HQ, Employee Strength, Business Segments)
15.2.3.2. Financials
15.2.3.3. Recent Development
15.2.3.4. Strategy
15.2.4. Gilead Sciences, Inc.
15.2.4.1. Overview (HQ, Employee Strength, Business Segments)
15.2.4.2. Financials
15.2.4.3. Recent Development
15.2.4.4. Strategy
15.2.5. GlaxoSmithKline plc
15.2.5.1. Overview (HQ, Employee Strength, Business Segments)
15.2.5.2. Financials
15.2.5.3. Recent Development
15.2.5.4. Strategy
15.2.6. Merck & Co., Inc.
15.2.6.1. Overview (HQ, Employee Strength, Business Segments)
15.2.6.2. Financials
15.2.6.3. Recent Development
15.2.6.4. Strategy
15.2.7. Mylan N.V.
15.2.7.1. Overview (HQ, Employee Strength, Business Segments)
15.2.7.2. Financials
15.2.7.3. Recent Development
15.2.7.4. Strategy
15.2.8. Novartis AG
15.2.8.1. Overview (HQ, Employee Strength, Business Segments)
15.2.8.2. Financials
15.2.8.3. Recent Development
15.2.8.4. Strategy
15.2.9. Pediapharm, Inc.
15.2.9.1. Overview (HQ, Employee Strength, Business Segments)
15.2.9.2. Financials
15.2.9.3. Recent Development
15.2.9.4. Strategy
15.2.10. Pfizer Inc.
15.2.10.1. Overview (HQ, Employee Strength, Business Segments)
15.2.10.2. Financials
15.2.10.3. Recent Development
15.2.10.4. Strategy
15.2.11. Sanofi S.A.
15.2.11.1. Overview (HQ, Employee Strength, Business Segments)
15.2.11.2. Financials
15.2.11.3. Recent Development
15.2.11.4. Strategy
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers